Biocon Biologics Partners with Sandoz Australia for Biosimilars Trastuzumab and Bevacizumab

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/26/2026

1. SPY
2. AKAM
3. COST
4. META
5. NVDA
6. ZS
7. AWK
8. DRI
9. ULS
10. VEON

Go back to Biocon Biologics Partners with Sandoz Australia for Biosimilars Trastuzumab and Bevacizumab
(NYSE: NSE) Delayed: 0.00 -22.48 (100%)
Previous Close $22.48    52 Week High $ 
Open $22.48    52 Week Low $ 
Day High $22.48    P/E N/A 
Day Low $22.48    EPS $ 
Volume 0